Compare PODD & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PODD | COO |
|---|---|---|
| Founded | 2000 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 16.5B |
| IPO Year | 2007 | 1994 |
| Metric | PODD | COO |
|---|---|---|
| Price | $215.93 | $71.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 11 |
| Target Price | ★ $357.65 | $90.18 |
| AVG Volume (30 Days) | 839.7K | ★ 1.9M |
| Earning Date | 05-07-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.48 | 0.66 |
| Revenue | ★ $2,708,100,000.00 | $2,532,800,000.00 |
| Revenue This Year | $24.33 | $6.66 |
| Revenue Next Year | $19.33 | $5.20 |
| P/E Ratio | ★ $64.99 | $106.99 |
| Revenue Growth | ★ 30.73 | 18.41 |
| 52 Week Low | $216.49 | $61.78 |
| 52 Week High | $354.88 | $89.83 |
| Indicator | PODD | COO |
|---|---|---|
| Relative Strength Index (RSI) | 29.20 | 33.78 |
| Support Level | N/A | $70.97 |
| Resistance Level | $299.75 | $75.61 |
| Average True Range (ATR) | 7.61 | 2.03 |
| MACD | -0.52 | -0.25 |
| Stochastic Oscillator | 1.66 | 25.73 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.